TRV
48
2
KMB
34
6
SLB
45
4
UNP
48
6
ROP
53
2
DD
64
9
PFG
36
3
MAS
59
3
DIS
52
3
MS
69
3
WU
36
2
KEY
34
3
CMA
53
3
XYL
35
4
FRT
41
5
COST
54
4
KMX
55
9
STI
28
9
SYY
45
2
CINF
40
5
TRV
48
2
KMB
34
6
SLB
45
4
UNP
48
6
ROP
53
2
DD
64
9
PFG
36
3
MAS
59
3
DIS
52
3
MS
69
3
WU
36
2
KEY
34
3
CMA
53
3
XYL
35
4
FRT
41
5
COST
54
4
KMX
55
9
STI
28
9
SYY
45
2
CINF
40
5
Financhill
Back

Madrigal Pharmaceuticals Vs. Intra-Cellular Therapies Industry Stock Comparison

Buy
68

MDGL
Madrigal Pharmaceuticals

Last Price:
338.08
Seasonality Move:
34.75%
Buy
63

ITCI
Intra-Cellular Therapies

Last Price:
89.41
Seasonality Move:
17.18%
Buy
68
Madrigal Pharmaceuticals (MDGL) is a Buy

Is Madrigal Pharmaceuticals a Buy, Sell or Hold?

  • The current Madrigal Pharmaceuticals [MDGL] share price is $337.61. The Score for MDGL is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Intra-Cellular Therapies (ITCI) is a Buy

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $89.24. The Score for ITCI is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • ITCI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MDGL Stock Price Chart

What is Madrigal Pharmaceuticals's stock price today?

  • The Madrigal Pharmaceuticals share price today is $337.61
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $89.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing buying pressure, which is a positive indicator for future bullish movement.

MDGL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 21.28 Buy
Relative Strength Index (14 RSI): 87.29 Buy
Chaikin Money Flow: 769814 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (188.5 - 266.7) Buy
Bollinger Bands (100): (220.63 - 281.81) Buy

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.18 Buy
Relative Strength Index (14 RSI): 76.99 Buy
Chaikin Money Flow: 460700 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (71.96 - 82.1) Buy
Bollinger Bands (100): (71.52 - 79.02) Buy

MDGL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 263.66 Buy
20-day SMA: 232.09 Buy
50-day SMA: 231.65 Buy
200-day SMA: 242.2 Buy
8-day EMA: 280.27 Buy
20-day EMA: 247.39 Buy
50-day EMA: 238.07 Buy
200-day EMA: 236.47 Buy

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 82.69 Buy
20-day SMA: 78.21 Buy
50-day SMA: 75.65 Buy
200-day SMA: 72.06 Buy
8-day EMA: 83.84 Buy
20-day EMA: 79.81 Buy
50-day EMA: 76.91 Buy
200-day EMA: 71.78 Buy

Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $4.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.14 per share, and an increase next year of $9.75 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $0.91 per share.

Madrigal Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):